AzTrials
AzTrials

Pressure InjuryNCT05441293

Determinants of the Success of Flap Reconstruction: Outcome Analysis of 484 Surgeries for Pressure Injury

An observational study of Pressure Injury, run by Taipei Medical University WanFang Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Pressure injury (PI) mainly occurs in bedridden older adults or those with physical limitations. PI treatment is typically long-term, requiring coordination between health-care workers and the patient's caregiver. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Pressure Injury
What is being tested?
flap reconstruction
Type of treatment
Surgery or procedure
How many people
484 participants
Where
No sites listed yet
Study dates
1 Jan 2016to 31 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: all patients who received debridement or flap reconstruction surgery for Pressure injury in Wan Fang Hospital from January 2016 to December 2021

Who may be able to join

  • all patients who received debridement or flap reconstruction surgery for Pressure injury in Wan Fang Hospital from January 2016 to December 2021

Who cannot join

  • the patients who did not received debridement or flap reconstruction surgery for Pressure injury

About this study

Official title: b Division of Plastic Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

Background: Pressure injury (PI) mainly occurs in bedridden older adults or those with physical limitations. PI treatment is typically long-term, requiring coordination between health-care workers and the patient's caregiver. Here, we aimed to determine the appropriate timing to conduct flap reconstruction in patients with PIs and identify factors affecting surgical outcomes.

Materials and Methods: We retrospectively reviewed the data of all patients who received debridement or flap reconstruction surgery for PIs in our hospital from January 2016 to December 2021. The extracted data included patient demographics, surgical records, blood test results, vital signs, and flap outcomes. Next, these characteristics including the flap outcomes of our patients with PIs were analyzed, along with the risk factors for poor wound healing and complications.

Conditions
Pressure Injury
Being tested
flap reconstruction
Medical subject headings
Pressure Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • flap reconstructionProcedure or surgery

    received flap reconstruction over sacrum, back, trochanter, ischium, elbow, and lower extremities

Study groups in NCT05441293
Study groupRoleWhat they receive
debridements groupDuring study peroid, the patient who received debridement surgery for pressure injury
Receives: Procedure: flap reconstruction
flap reconstructions groupDuring study peroid, the patient who received flap reconstruction surgery for pressure injury
Receives: Procedure: flap reconstruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Complete wound healing

    no presentation of wound drainage or wound dehiscence at the surgical site 14 days after drainage tube removal.

    Measured: from January 2016 to December 2021

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2022
  2. Study start1 Jan 2016
  3. Primary completion1 Dec 2021
  4. Study completion31 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
484 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05441293
Sponsor's protocol ID
WanFangW2
Status last verified
Jun 2022
First submitted
28 Jun 2022
Last updated
1 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: the data are not available for sharing.

Questions about this trial

What is this clinical trial studying?

An observational study of Pressure Injury, run by Taipei Medical University WanFang Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Complete wound healing (time frame: from January 2016 to December 2021). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in